31 results
424B3
MDWD
MediWound Ltd
6 Apr 23
Prospectus supplement
4:06pm
not expect that we will be classified as a PFIC for the taxable year ended December 31, 2023. There can be no assurance that we will not be considered … the information necessary for U.S. holders to make qualified electing fund elections if we are classified as a PFIC. U.S. holders should consult their tax
POS AM
MDWD
MediWound Ltd
31 Mar 23
Prospectus update (post-effective amendment)
7:00am
gross assets and the nature of our business, we do not expect that we will be classified as a PFIC for the taxable year ended December 31, 2023 … shares. However, we do not intend to provide the information necessary for U.S. holders to make qualified electing fund elections if we are classified
424B3
MDWD
MediWound Ltd
25 Nov 22
Prospectus supplement
5:10pm
of this offering, and the nature of our business, we do not expect that we will be classified as a PFIC for the taxable year ended December 31, 2022 … . However, we do not intend to provide the information necessary for U.S. holders to make qualified electing fund elections if we are classified
6-K
EX-99.2
MDWD
MediWound Ltd
15 Nov 22
MediWound Reports Third Quarter 2022 Financial Results and Provides Company Update
7:05am
price of $1.925 per ordinary share which will expire in four years from the Authorized Share Increase Date.
The warrants issued have been classified
F-1
ul5lmk4
10 Nov 22
Registration statement (foreign)
4:13pm
6-K
EX-99.2
kon pafx39
9 Nov 22
Current report (foreign)
4:05pm
6-K
EX-99.1
slt3 qu4j1tu2os
21 Oct 22
Current report (foreign)
4:05pm
6-K
EX-10.1
fc3zm7g1
26 Sep 22
MediWound Announces Concurrent Registered Direct
4:05pm
6-K
EX-10.2
jmjbyl23v7tg
26 Sep 22
MediWound Announces Concurrent Registered Direct
4:05pm
424B5
c24pjemmbb1fm
22 Sep 22
Prospectus supplement for primary offering
5:16pm
424B5
jtq7bd1ca f1afz
3 Mar 22
Prospectus supplement for primary offering
4:45pm
6-K
EX-1.1
r91buptxm
3 Mar 22
MediWound Announces Pricing of Public Offering of Ordinary Shares
4:09pm
424B3
1qk vlgmhmi9mjtjtuo
2 Mar 22
Prospectus supplement
4:53pm
6-K
EX-99.2
etnif
20 May 20
MediWound Reports First Quarter 2020 Financial Results and Provides Corporate Update
7:05am
6-K
EX-1.1
k82lxch2b 4pt
25 Feb 20
Open Market Sale Agreementsm
5:23pm
6-K
EX-99.1
step2 zgvd20111
25 Feb 20
MediWound Reports Fourth Quarter and Full-Year 2019 Financial Results
7:05am